Cerebellum’s Athenahealth, Inc. ATHN Stock Holding History

Cerebellum’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,301	Closed	-$174K	–	574
2018 Q3	$174K	Buy	1,301 +193	+17%	+$28.9K	0.28%	269
2018 Q2	$176K	Buy	+1,108	New	+$164K	0.29%	144

Other funds holding ATHN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Cerebellum's ATHN Position: Q4 2018 in Review

Cerebellum sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 1,301 shares — an estimated $174K sold.

Cerebellum first reported a position in ATHN in Q2 2018 and held it in 2 quarters. The position peaked at $176K in Q2 2018. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

Cerebellum reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
Cerebellum sold 1,301 Athenahealth, Inc. shares in Q4 2018, an estimated $174K.
Cerebellum first reported a position in Athenahealth, Inc. in Q2 2018 and held it in 2 quarters.
Cerebellum's Athenahealth, Inc. position peaked at $176K in Q2 2018.
263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Cerebellum's 13F filing for Q4 2018, filed 10 Jan 2019.